ConductScience.org, home

Paper3908514

Atopic eczema unresponsive to evening primrose oil (linoleic and gamma-linolenic acids).

Bamford JT and 2 others. J Am Acad Dermatol, 1985. Cited by 93 papers, by iCite.

Cite this record

ConductScience Library. Atopic eczema unresponsive to evening primrose oil (linoleic and gamma-linolenic acids). Papers, record 3908514. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3908514

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Atopic eczema unresponsive to evening primrose oil (linoleic and gamma-linolenic acids).
PubMed
Journal
J Am Acad Dermatol
PubMed
Year
1985
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
93
iCite
Relative citation ratio, by iCite
5.42
iCite
Revised in PubMed
2022-03-18
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bamford JTJ T
2Gibson RWR W
3Renier CMC M

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Dermatitis, AtopicMajor topic
Dermatologic AgentsMajor topic
Fatty Acids, EssentialMajor topic
Fatty Acids, UnsaturatedMajor topic
Administration, Oral
Adolescent
Adult
Aged
Child
Child, Preschool
Clinical Trials as Topic
Double-Blind Method
Humans
Linoleic Acids
Middle Aged
Oenothera biennis
Plant Oils
Random Allocation
gamma-Linolenic Acid

Source PubMed

Download CSV of topics

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.

PMIDTitleJournalYearIn PapersSource
38360611The effect of Oenothera biennis (Evening primrose) oil on inflammatory diseases: a systematic review of clinical trials.BMC Complement Med Ther2024https://conductscience.org/library/papers/38360611PubMed
34200727A Systematic Review and Meta-Analysis of the Efficacy of Evening Primrose Oil for Mastalgia Treatment.Int J Environ Res Public Health2021https://conductscience.org/library/papers/34200727PubMed
30402601Complementary and alternative medicine (CAM) and atopic eczema.Allergol Select2017https://conductscience.org/library/papers/30402601PubMed
30065580Effect of Evening Primrose Oil on Korean Patients With Mild Atopic Dermatitis: A Randomized, Double-Blinded, Placebo-Controlled Clinical Study.Ann Dermatol2018https://conductscience.org/library/papers/30065580PubMed
28861804Therapeutic Benefits of Natural Ingredients for Atopic Dermatitis.Chin J Integr Med2018https://conductscience.org/library/papers/28861804PubMed
25264237Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches.J Am Acad Dermatol2014https://conductscience.org/library/papers/25264237PubMed
24003269Dose-dependent effects of evening primrose oil in children and adolescents with atopic dermatitis.Ann Dermatol2013https://conductscience.org/library/papers/24003269PubMed
23633319Oral evening primrose oil and borage oil for eczema.Cochrane Database Syst Rev2013https://conductscience.org/library/papers/23633319PubMed
18750675Diet and atopic dermatitis.West J Med1989https://conductscience.org/library/papers/18750675PubMed
18163227Treatment of eczema.Clin Rev Allergy Immunol2007https://conductscience.org/library/papers/18163227PubMed
14670885Efficacy and tolerability of borage oil in adults and children with atopic eczema: randomised, double blind, placebo controlled, parallel group trial.BMJ2003https://conductscience.org/library/papers/14670885PubMed
14670851Evening primrose oil for atopic dermatitis.BMJ2003https://conductscience.org/library/papers/14670851PubMed
9014601Epogam evening primrose oil treatment in atopic dermatitis and asthma.Arch Dis Child1996https://conductscience.org/library/papers/9014601PubMed
7950599Evening primrose oil.BMJ1994https://conductscience.org/library/papers/7950599PubMed
7819863Evening primrose oil. Does not show promise in atopic dermatitis.BMJ1994https://conductscience.org/library/papers/7819863PubMed
7711624Management of atopic eczema. Joint Workshop of the British Association of Dermatologists and the Research Unit of the Royal College of Physicians of London.BMJ1995https://conductscience.org/library/papers/7711624PubMed
3147017Role of diet in treating atopic eczema: dietary manipulation has no value.BMJ1988https://conductscience.org/library/papers/3147017PubMed
2066937Recent developments in the treatment of childhood atopic eczema.J R Coll Physicians Lond1991https://conductscience.org/library/papers/2066937PubMed
1943500Supplementation with evening primrose oil in atopic dermatitis: effect on fatty acids in neutrophils and epidermis.Lipids1991https://conductscience.org/library/papers/1943500PubMed
1920221Atopic eczema.J R Coll Physicians Lond1991https://conductscience.org/library/papers/1920221PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3908514

GET https://conductscience.org/api/papers/v1/3908514/cited_by?page=2